Want to join the conversation?
$BBT, which competes with $RF, $BAC and $STI, said that it grew 4Q15 revenues to $2.6Bil, up $164MM vs. 4Q14, including acquisitions, and were able to deliver stable net interest margins. Annualized revenue was 10.8%. The company's GAAP ROA was 1.03%, while return on average tangible common shareholders' equity was 13.37% for the quarter.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)